Overview

Comparison of Nexium Versus Secretol in the Healing and Controlling of Symptoms in GERD Patients With Severe EE.

Status:
Unknown status
Trial end date:
2015-05-01
Target enrollment:
Participant gender:
Summary
To compare the complete healing of erosive esophagitis(EE) after 3 weeks of treatment with Secretol 80/80 versus Nexium 40 mg daily.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Effexus Pharmaceutical
Collaborator:
Southern Arizona VA Health Care System
Treatments:
Esomeprazole
Lansoprazole
Omeprazole